Ven Bio Partners LLC Pharvaris N.V. Put Options Transaction History
Ven Bio Partners LLC
- $256 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PHVS
# of Institutions
35Shares Held
37.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$128 Million4.07% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.04MShares$68.7 Million47.16% of portfolio
-
Viking Global Investors LP3.65MShares$62.1 Million0.32% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$57.7 Million6.74% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$56.2 Million11.53% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $574M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...